Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care

view original post

SAN FRANCISCO–(BUSINESS WIRE)–Jul 29, 2025–

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today released new data showing that its personalized, digital-first approach to weight loss is driving meaningful, sustainable results, laying the groundwork for lasting success. In a first-of-its-kind U.S. analysis of treatment plans, including compounded GLP-1s, customers taking a compounded GLP-1 reported losing an average of 20.9 pounds or 10.3% of initial body weight, within six months, while reporting a low rate of side effects. Just as importantly, 75% of customers remained on treatment plans in the same timeframe, a powerful signal of real-world trust and clinical success. 1

This page requires Javascript.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

‘;
var element = document.getElementById(“sub_message”);
element.appendChild(subMessage);
console.log(“Code Loaded!”);
} else {
var subMessage = document.createElement(‘div’);
subMessage.id = ‘sub-message-top’;
subMessage.class = ‘panel panel-default’;
subMessage.style.backgroundColor = ‘#eee’;
subMessage.style.borderRadius = ‘5px’;
subMessage.style.padding = ’10px’;
subMessage.style.marginTop = ’25px’;
subMessage.style.marginBottom = ’25px’;
subMessage.innerHTML =

Support local journalism.

Subscribe Today‘;
var element = document.getElementById(“sub_message”);
element.appendChild(subMessage);
console.log(“Code Loaded!”);
}
}